Reconstructing robust phylogenies of metastatic cancers

A comprehensive understanding of the clonal evolution of cancer is critical for understanding neoplasia. Genome-wide sequencing data enables evolutionary studies at unprecedented depth. However, classical phylogenetic methods often struggle with noisy sequencing data of impure DNA samples and fail to detect subclones that have different evolutionary trajectories. We have developed a tool, called Treeomics, that allows us to reconstruct the phylogeny of a cancer with commonly available sequencing technologies. Using Bayesian inference and Integer Linear Programming, robust phylogenies consistent with the biological processes underlying cancer evolution were obtained for pancreatic, ovarian, and prostate cancers. Furthermore, Treeomics correctly identified sequencing artifacts such as those resulting from low statistical power; nearly 7% of variants were misclassified by conventional statistical methods. These artifacts can skew phylogenies by creating illusory tumor heterogeneity among distinct samples. Importantly, we show that the evolutionary trees generated with Treeomics are mathematically optimal.

[1]  Joshua F. McMichael,et al.  The Origin and Evolution of Mutations in Acute Myeloid Leukemia , 2012, Cell.

[2]  K. Kinzler,et al.  Genetic instabilities in human cancers , 1998, Nature.

[3]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[4]  Arne Traulsen,et al.  Cancer initiation with epistatic interactions between driver and passenger mutations. , 2013, Journal of theoretical biology.

[5]  A. McKenna,et al.  Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia , 2012, Cell.

[6]  Benjamin J. Raphael,et al.  THetA: inferring intra-tumor heterogeneity from high-throughput DNA sequencing data , 2013, Genome Biology.

[7]  Z. Szallasi,et al.  Spatial and temporal diversity in genomic instability processes defines lung cancer evolution , 2014, Science.

[8]  Junfeng Wang,et al.  Inferring Clonal Composition from Multiple Sections of a Breast Cancer , 2014, PLoS Comput. Biol..

[9]  Nam Huh,et al.  Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination , 2015, Proceedings of the National Academy of Sciences.

[10]  M. Nowak,et al.  Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.

[11]  Natalia L. Komarova,et al.  Dynamics of Cancer: Mathematical Foundations of Oncology , 2014 .

[12]  Yu Cao,et al.  Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing , 2014, Science.

[13]  F. Markowetz,et al.  Cancer Evolution: Mathematical Models and Computational Inference , 2014, Systematic biology.

[14]  N. McGranahan,et al.  Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. , 2015, Cancer cell.

[15]  David Haussler,et al.  The infinite sites model of genome evolution , 2008, Proceedings of the National Academy of Sciences.

[16]  Benjamin J. Raphael,et al.  Reconstruction of clonal trees and tumor composition from multi-sample sequencing data , 2015, Bioinform..

[17]  P. A. Futreal,et al.  Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing , 2014, Nature Genetics.

[18]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[19]  Johannes G. Reiter,et al.  The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers , 2012, Nature.

[20]  Andrew Menzies,et al.  The patterns and dynamics of genomic instability in metastatic pancreatic cancer , 2010, Nature.

[21]  David G. Knowles,et al.  Fast Computation and Applications of Genome Mappability , 2012, PloS one.

[22]  Evis Sala,et al.  Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis , 2015, PLoS medicine.

[23]  M. Gerstung,et al.  Reliable detection of subclonal single-nucleotide variants in tumour cell populations , 2012, Nature Communications.

[24]  P. Nowell The clonal evolution of tumor cell populations. , 1976, Science.

[25]  N. McGranahan,et al.  Inferring mutational timing and reconstructing tumour evolutionary histories. , 2015, Biochimica et biophysica acta.

[26]  Krishnendu Chatterjee,et al.  Evolutionary dynamics of cancer in response to targeted combination therapy , 2013, eLife.

[27]  M. Stratton,et al.  Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing , 2008, Proceedings of the National Academy of Sciences.

[28]  I. Fidler,et al.  AACR centennial series: the biology of cancer metastasis: historical perspective. , 2010, Cancer research.

[29]  Simon Tavaré,et al.  multiSNV: a probabilistic approach for improving detection of somatic point mutations from multiple related tumour samples , 2015, Nucleic acids research.

[30]  Woo Suk Hong,et al.  Inferring the Origin of Metastases from Cancer Phylogenies. , 2015, Cancer research.

[31]  James D. Brenton,et al.  Phylogenetic Quantification of Intra-tumour Heterogeneity , 2013, PLoS Comput. Biol..

[32]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[33]  Paula D. Bos,et al.  Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.

[34]  M. Nykter,et al.  The Evolutionary History of Lethal Metastatic Prostate Cancer , 2015, Nature.

[35]  Shankar Vembu,et al.  PhyloWGS: Reconstructing subclonal composition and evolution from whole-genome sequencing of tumors , 2015, Genome Biology.

[36]  Brian T. Lee,et al.  The UCSC Genome Browser database: 2015 update , 2014, Nucleic Acids Res..

[37]  Robert T. Jones,et al.  Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. , 2015, Cancer discovery.

[38]  W. Fitch Toward Defining the Course of Evolution: Minimum Change for a Specific Tree Topology , 1971 .

[39]  Andrew Menzies,et al.  Analysis of the Genetic Phylogeny of Multifocal Prostate Cancer Identifies Multiple Independent Clonal Expansions in Neoplastic and Morphologically Normal Prostate Tissue , 2015, Nature Genetics.

[40]  R. Jain,et al.  Using tumour phylogenetics to identify the roots of metastasis in humans , 2015, Nature Reviews Clinical Oncology.

[41]  Ali Bashashati,et al.  Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling , 2013, The Journal of pathology.

[42]  Steven J. M. Jones,et al.  Circos: an information aesthetic for comparative genomics. , 2009, Genome research.

[43]  Sohrab P. Shah,et al.  TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data , 2014, Genome research.

[44]  A. Børresen-Dale,et al.  The Life History of 21 Breast Cancers , 2012, Cell.

[45]  C. Maley,et al.  Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .

[46]  Obi L. Griffith,et al.  SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution , 2014, PLoS Comput. Biol..

[47]  S. Kasif,et al.  Hypermutable DNA chronicles the evolution of human colon cancer , 2014, Proceedings of the National Academy of Sciences.

[48]  Ted K. Ralphs,et al.  Integer and Combinatorial Optimization , 2013 .

[49]  Alessandro Romanel,et al.  Unraveling the clonal hierarchy of somatic genomic aberrations , 2014, Genome Biology.

[50]  Dan Gusfield,et al.  Efficient algorithms for inferring evolutionary trees , 1991, Networks.

[51]  A. Bouchard-Côté,et al.  PyClone: statistical inference of clonal population structure in cancer , 2014, Nature Methods.

[52]  Philipp M. Altrock,et al.  The mathematics of cancer: integrating quantitative models , 2015, Nature Reviews Cancer.